-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on TriSalus Life Sciences, Maintains $11 Price Target

Benzinga·03/28/2025 15:17:27
Listen to the news
Canaccord Genuity analyst William Plovanic maintains TriSalus Life Sciences (NASDAQ:TLSI) with a Buy and maintains $11 price target.